The Australian share market may not have a tech sector that is comparable to the one in the United States, but that doesn't mean there aren't any world-class ASX 200 tech stocks to invest in.

For example, the two stocks listed below are high-quality and have just been named as buys by analysts at Morgans. Here's what the broker is saying about them:

Aristocrat Leisure Ltd (ASX: ALL)

Morgans thinks that investors should be buying gaming technology giant Aristocrat Leisure.

While the broker was a touch disappointed with its recent half year results release, it wasn't enough to put it off. Especially given its belief that the weakness was driven by a short-term timing and mix issue and is not a structural change in the market.

In light of this, it sees recent share price weakness as a buying opportunity for investors. The broker said:

Aristocrat Leisure's (ALL) 1H25 result had the potential to be a messy one, following the Plarium divestment and limited visibility on the nascent Interactive unit. What we did not foresee was a ~5% shortfall in the core land-based division vs MorgansF and consensus expectations, caused by softer leased FPD and adverse mix in North America. ALL has a proven record of delivering on result day; however, with the shares trading at more than twice its closest peer multiple, even a modest earnings dip is severely punished by the market.

Shares were down as much as 15% intraday but have steadily recovered since. Despite the miss, we see no structural change in market dynamics and regard the weakness as a short-term timing and mix issue. Importantly, management reiterated its qualitative guidance of constant currency NPATA growth in FY25 (MorgansF:~4%). Following the result, our FY26-27F EPSA estimates reduce by 6-7 %.

Morgans has an add rating and $71.00 price target on its shares.

Xero Ltd (ASX: XRO)

Analysts at Morgans have also named cloud accounting platform provider Xero as an ASX 200 tech stock to buy.

In response to its FY 2025 results, it notes that "North America is looking more promising" and was pleased with the management of costs and its improved sales traction. So much so, it upgraded its shares following the result. It said:

XRO's result and outlook commentary were largely inline with expectations. For us, the highlights of the result was improved sales traction and tight cost management, which are supportive of accelerated investment in growth. We upgrade our Target Price to A$215 and our rating to an Add (from Hold).

As mentioned above, Morgans now has an add rating and $215.00 price target on its shares.